48,830
edits
Difference between revisions of "Invasive breast cancer"
Jump to navigation
Jump to search
Invasive breast cancer (view source)
Revision as of 19:20, 18 September 2011
, 19:20, 18 September 2011→Characteristics of the subtypes: more
m (→Microscopic) |
|||
| Line 134: | Line 134: | ||
*Medullary carcinoma. | *Medullary carcinoma. | ||
*Mucinous carinoma. | *Mucinous carinoma. | ||
*Neuroendocrine | *[[Metaplastic carcinoma]]. | ||
*[[Neuroendocrine tumour]]. | |||
*Apocrine carcinoma - need 90% apocrine morphology,<ref name=Ref_BP217>{{Ref BP|217}}</ref> smaller tumours classically AR+, GCDFP-15+.<ref name=pmid16045781>{{Cite journal | last1 = Honma | first1 = N. | last2 = Takubo | first2 = K. | last3 = Akiyama | first3 = F. | last4 = Sawabe | first4 = M. | last5 = Arai | first5 = T. | last6 = Younes | first6 = M. | last7 = Kasumi | first7 = F. | last8 = Sakamoto | first8 = G. | title = Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. | journal = Histopathology | volume = 47 | issue = 2 | pages = 195-201 | month = Aug | year = 2005 | doi = 10.1111/j.1365-2559.2005.02181.x | PMID = 16045781 }}</ref> | *Apocrine carcinoma - need 90% apocrine morphology,<ref name=Ref_BP217>{{Ref BP|217}}</ref> smaller tumours classically AR+, GCDFP-15+.<ref name=pmid16045781>{{Cite journal | last1 = Honma | first1 = N. | last2 = Takubo | first2 = K. | last3 = Akiyama | first3 = F. | last4 = Sawabe | first4 = M. | last5 = Arai | first5 = T. | last6 = Younes | first6 = M. | last7 = Kasumi | first7 = F. | last8 = Sakamoto | first8 = G. | title = Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. | journal = Histopathology | volume = 47 | issue = 2 | pages = 195-201 | month = Aug | year = 2005 | doi = 10.1111/j.1365-2559.2005.02181.x | PMID = 16045781 }}</ref> | ||
*Lipid-rich carcinoma. | *Lipid-rich carcinoma. | ||
| Line 142: | Line 143: | ||
Epithelial tumours seen in the [[salivary gland]]: | Epithelial tumours seen in the [[salivary gland]]: | ||
*Adenoid cystic carcinoma | *[[Adenoid cystic carcinoma]]. | ||
*Acinic cell carcinoma. | *[[Acinic cell carcinoma]]. | ||
*Carcinoma ex pleomorphic adenoma. | |||
Seen in the skin: | |||
*[[Sebaceous carcinoma]]. | |||
Clinically diagnosed: | Clinically diagnosed: | ||
| Line 149: | Line 154: | ||
In situ lesions: | In situ lesions: | ||
*Ductal carcinoma in situ. | *[[Ductal carcinoma in situ]]. | ||
*Lobular carcinoma in situ. | *[[Lobular carcinoma in situ]]. | ||
Proliferative lesions: | Proliferative lesions: | ||
*Usual ductal hyperplasia. | *[[Usual ductal hyperplasia]]. | ||
*Flat epithelial atypia. | *[[Flat epithelial atypia]]. | ||
*Atypical ductal hyperplasia. | *[[Atypical ductal hyperplasia]]. | ||
Non-specific: | |||
*Microinvasive carcinoma. | |||
Papillary: | |||
*Papilloma. | |||
*Atypical papilloma. | |||
*Intraductal papillary carcinoma. | |||
Adenomas: | |||
*Ductal adenoma. | |||
*Tubular adenoma. | |||
*Lactating adenoma. | |||
*Apocrine adenoma. | |||
*Pleomorphic adenoma. | |||
====Myoepithelial==== | |||
*Myoepitheliosis. | |||
*Adenomyoepithelial adenosis. | |||
*[[Adenomyoepithelioma]]. | |||
*Malignant adenomyoepithelioma. | |||
====Mesenchymal tumours==== | |||
:See: ''[[Soft tissue lesions]]''. | |||
====Fibroepithelial tumours==== | |||
*[[Fibroadenoma]]. | |||
*[[Phyllodes tumour]]. | |||
*Periductal stromal sarcoma, low grade. | |||
*Mammary hamartoma. | |||
====Nipple lesions==== | |||
*Nipple adenoma. | |||
*Syringomatous adenoma. | |||
*[[Paget disease of the breast]]. | |||
====Other==== | |||
*[[Lymphoma]]. | |||
*Metastasis. | |||
==Ductal carcinoma== | ==Ductal carcinoma== | ||